Fuji PharmaFuji Pharma Co.,Ltd.4554東証プライム医薬品FY ending Sep 2025, consolidated, J-GAAP

Fuji Pharma FY ending Sep 2019 results

Fuji Pharma brought in ¥36.3B in revenue.

Out of every ¥100 of sales, about ¥12 is left as operating profit.

Where the money goes

For every ¥100 Fuji Pharma sells, how much goes where, and how much is kept.

FY ending Sep 2019

Margin funnel (derived from reported values)Gross margin 43.5% → Operating margin 11.5% → Net margin 8.2%

Show source documents (3)

EDINET (FSA Japan)
有価証券報告書－第59期(2022/10/01－2023/09/30)
ID S100SI942023-12-21Open
EDINET (FSA Japan)
有価証券報告書－第57期(令和2年10月1日－令和3年9月30日)
ID S100N2LZ2021-12-20Open
EDINET (FSA Japan)
有価証券報告書－第56期(令和1年10月1日－令和2年9月30日)
ID S100KDTI2020-12-18Open

Extracted from XBRL: 49 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.